Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Fabric8Labs is a machinery company that specializes in metal 3D printing.
Chaos is a defense technology company that develops advanced sensing, detection, and communication technologies for the military sectors.
Greenlight is a debit card and money app that provides an all-in-one money management platform for families and parents.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Clio provides cloud-based legal practice management software, helping law firms manage cases, billing, and client relationships.
Ouroboros Medicines is a biotechnology company specializes in immunology.
FiscalNote uses artificial intelligence and big data to deliver predictive analytics on government information to determine its impact.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Pluribus Networks is a leader in open networking and next generation software defined networking (SDN)
Wizard operates a commerce technology startup to transform e-commerce with conversational AI.
Neural Magic provides AI inference solutions for deploying open-source LLMs.
Contra is a networking platform that gives users the freedom and opportunity to work independently.
Cardionomic is a medical device developer that treats reduced cardiac output.
Expel is a security operations provider that offers managed detection and response, remediation, phishing support, and threat hunting.
Spiras Health is an operator of a healthcare company intended to extend the care of a patient dealing with complex chronic illness.
Synthesia is an AI video platform that enables users to create videos from text using advanced AI avatars and voiceovers.
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
Propense.ai is a SaaS platform that identifies new revenue streams for businesses, augmented with AI technology.
Evernow develops an online teleconsultation platform that focuses on women's long-term health.
Attest is a consumer research platform that delivers consumer data that drive predictable and repeatable growth to businesses.
Stride Health is a provider of an insurance recommendation platform designed to offer health insurance services.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Outrider develops robotic software and systems to automate logistics hub operations.
New Enterprise Associates has invested in 637 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Health Care, Artificial Intelligence (AI), Software, Biotechnology, Life Science. The firm invests across 73 different industry categories.
Among tracked funding rounds, Resilience received $825.0M in a Debt Financing round. New Enterprise Associates's total known invested capital is $35.0B.
New Enterprise Associates's average investment size is $68.3M across its portfolio of 637 companies.
Recent New Enterprise Associates portfolio additions include Arcellx, Fabric8Labs, Chaos, Greenlight, House Rx. These companies were founded in 2020 or later.